AZD0156 |
AZD0156 : Inhibitor of ATM
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| ATM |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Kinome selectivity data generated using DiscoveRx KINOMEscan™ screening platform with AZD0156 screen ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
ATR cell. IC50 = 6.2 µM, mTOR cell IC50 = 0.61 µM, PI3Ka IC50 = 1.4 µM
Potency Cellular
In Vitro
ATM
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.7b01896
In Vivo Validations
Rat
Dose:
Route of delivery:
Oral
Plasma half life:
4.4 h
Systemic clearance:
15.5 mL/min/kg
Bioavailability:
57%
Volume of Distribution at Steady-State:
4.3 L/kg
DOI Reference: 10.1021/acs.jmedchem.7b01896
Dog
Dose:
Route of delivery:
Oral
Plasma half life:
7.6 h
Systemic clearance:
33.3 mL/min/kg
Bioavailability:
54%
Volume of Distribution at Steady-State:
17.6 L/kg
DOI Reference: 10.1021/acs.jmedchem.7b01896
Mouse
Dose: 5 mg/Kg
Route of delivery:
Oral
Target engagement assay:
Immunocompromised mice SW620 xenograft model in combination with irinotecan. Or immunocompromised mice bearing HBCx-10 patient derived tumors in combination with olaparib.
DOI Reference: 10.1021/acs.jmedchem.7b01896
Chemical Information
| Molecular Formula | C26H31N5O3 |
| SMILEs | CN(C)CCCOc1ccc(-c2ccc3ncc4c(c3c2)n(C2CCOCC2)c(=O)n4C)cn1 |
| InChI | InChI=1S/C26H31N5O3/c1-29(2)11-4-12-34-24-8-6-19(16-28-24)18-5-7-22-21(15-18)25-23(17-27-22)30(3)26(32)31(25)20-9-13-33-14-10-20/h5-8,15-17,20H,4,9-14H2,1-3H3 |
| Molecular weight | 461.24 Da |
| AlogP | 0.0 |
| HBond acceptors | 8 |
| HBond donors | -- |
| Atoms | 65 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.